Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Polish Journal of Surgery

The Journal of Foundation of the Polish Journal of Surgery

12 Issues per year

CiteScore 2016: 0.29

SCImago Journal Rank (SJR) 2016: 0.166
Source Normalized Impact per Paper (SNIP) 2016: 0.207

Open Access
See all formats and pricing
More options …
Volume 79, Issue 2


Somatostatinoma of the Pancreas; Difficulties in Preoperative Diagnostic Approaches — A Case Report

Daria Dranka-Bojarowska / Marek Olakowski / Paweł Lampe
Published Online: 2007-09-24 | DOI: https://doi.org/10.2478/v10035-007-0021-y

Somatostatinoma of the Pancreas; Difficulties in Preoperative Diagnostic Approaches — A Case Report

Somatostatinoma is the rarest neuroendocrine tumor of the digestive tract. About 60% of somatostatinomas arise in the pancreas. This study presents a case of a 51-year-old male patient with tumor of the pancreas. Despite wide preoperative diagnostic examinations, it was impossible to determine the histological type of the tumor preoperatively. The patient was qualified for surgical procedure, during which the tumor was enucleated. The tumor was classified as somatostatinoma through immunohistochemical examination. The postoperative course was complicated by a small fluid collection, which arose in area of enucleation; the cistern was absorbed spontaneously. Currently, the patient is under surgical ambulatory care and is in general, in good condition.

Keywords: somatostatinoma; pancreatic neuroendocrine neoplasms; gastroenteropancreatic neuroendocrine tumors — GEP-NET

  • Harris GJ, Tio F, Cruz AB Jr: Somatostatinoma: a case report and review of the literature. J Surg Oncol 1987; 36: 8-16.CrossrefGoogle Scholar

  • Bolanowski M, Kos-Kudła B: Etiologia, występowanie, podział kliniczny i objawy guzów GEP. Onkologia po Dyplomie. Wydanie specjalne. 2005; 7-10.Google Scholar

  • Azimuddin K, Chamberlain RS: The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am 2001; 81: 511-25.CrossrefPubMedWeb of ScienceGoogle Scholar

  • House MG, Yeo CJ, Schulick RD: Periampullary pancreatic somatostatinoma. Ann Surg Oncol 2002; 9: 869-74.CrossrefPubMedGoogle Scholar

  • Vinik AL, Strodel WE, Eckhauser FE et al.: Somatostatinomas, Pomas, neurotensinomas. Semin Oncol 1987; 14: 263-81.Google Scholar

  • Franek E: Hormonalnie czynne neuroendokrynne guzy trzustki. Przegl Gastroenterol 2006; 1: 22-28.Google Scholar

  • Soga J, Yakuwa Y: Somatostatinoma inhibitory syndrome:a statistical evaluation of 173 reported cases as compared to other pancreatic endocrino-mas. J Exp Clin Cancer Res 1999; 18: 13-22.Google Scholar

  • Mullan MH, Gauger PG, Thompson NW: Endocrine tumors of the pancreas: review and recent advances. ANZ J Surg 2001; 71: 475-82.PubMedCrossrefGoogle Scholar

  • Kaltsas GA, Besser GM, Grossman AB: Diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 2004; 25: 458-511.CrossrefPubMedGoogle Scholar

  • Anderson MA, Carpenter S, Thompson NW et al.: Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of pancreas. Am J Gastroenterol 2000; 95: 2271-77.CrossrefGoogle Scholar

  • Tjon A, Tham RT, Jansen JB et al.: Imaging features of somatostatinoma: MR, CT, US and angiography. J Comput Assist Tomogr 1994; 18: 427-31.Google Scholar

  • Semelka RC, Custodio CM, Cem Balci M et al.: Neuroendocrine tumors of pancreas: spectrum of appearances on MRI. J Magn Reson Imaging 2000; 11: 141-48.CrossrefGoogle Scholar

  • Marakis G, Ballas K, Rafailidis S et al.: Somatostatin-producing pancreatic endocrine carcinoma presented as relapsing cholangitis — a case report. Pancreatology 2005; 5: 295-99.CrossrefGoogle Scholar

  • Becherer A, Szabo M, Karanikas G et al.: Imaging of advanced neuroendocrine tumors with 18F-FDOPA PET. J Nucl Med 2004; 45: 1161-67.Google Scholar

  • Norton JA, Cromack DT, Shawker TH: Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. Ann Surg 1988; 207: 160-68.PubMedCrossrefGoogle Scholar

  • Ramage JK, Davies AHG, Ardill J et al.: Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005; 54: 1-16.Web of ScienceGoogle Scholar

  • Plöckinger U, Wiedenmann B: Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours. Neuroendocrinology 2004; 80: 35-38.CrossrefPubMedGoogle Scholar

  • Brentjens R, Saltz L: Islet cell tumors of the pancreas: the medical oncologist's perspective. Surg Clin North Am 2001; 81: 527-542.CrossrefGoogle Scholar

  • Cichocki A: Chirurgiczne leczenie guzów neuroendokrynnych przewodu pokarmowego. Onkologia po Dyplomie. Wydanie specjalne. 2005; 42-46.Google Scholar

  • Madeira I, Terris B, Voss M et al.: Prognostic factor in patients with endocrine tumors of the duodenopancreatic area. Gut 1998; 43: 422-27.CrossrefGoogle Scholar

About the article

Published Online: 2007-09-24

Published in Print: 2007-02-01

Citation Information: Polish Journal of Surgery, Volume 79, Issue 2, Pages 129–133, ISSN (Print) 0032-373X, DOI: https://doi.org/10.2478/v10035-007-0021-y.

Export Citation

This content is open access.

Comments (0)

Please log in or register to comment.
Log in